Press Releases

August 16, 2022

Summary Toggle Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation
August 9, 2022

Summary Toggle ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
August 8, 2022

Summary Toggle Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy
July 15, 2022

Summary Toggle Endo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada
July 1, 2022

Summary Toggle Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor
July 1, 2022

Summary Toggle Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants with Adhesive Capsulitis of the Shoulder
June 13, 2022

Summary Toggle Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain
June 9, 2022

Summary Toggle National Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Their Mental and Sexual Health; New Partnership Aims to Change That Through Education and Free Virtual Consultations
May 5, 2022

Summary Toggle ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS
May 5, 2022

Summary Toggle Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting
May 2, 2022

Summary Toggle Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
April 20, 2022

Summary Toggle Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo
April 12, 2022

Summary Toggle Endo to Announce First-Quarter 2022 Financial Results
March 28, 2022

Summary Toggle Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials
March 3, 2022

Summary Toggle Endo Launches New Living Our Values Program to Recognize Outstanding Team Members
March 2, 2022

Summary Toggle Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events
February 28, 2022

Summary Toggle ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS
February 11, 2022

Summary Toggle Endo Comments on Default Judgment on Liability in Tennessee State Court
February 7, 2022

Summary Toggle Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles
January 25, 2022

Summary Toggle Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results
January 18, 2022

Summary Toggle Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims
January 17, 2022

Summary Toggle Paladin Labs Announces the Launch of Xydalba® (dalbavancin for injection) in Canada
January 13, 2022

Summary Toggle Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism
January 11, 2022

Summary Toggle Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development
January 10, 2022

Summary Toggle Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education Unfold
January 4, 2022

Summary Toggle Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution
January 4, 2022

Summary Toggle Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference
December 23, 2021

Summary Toggle Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims
December 23, 2021

Summary Toggle Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI® (Cenobamate) in Canada
December 15, 2021

Summary Toggle Endo Announces Favorable Final Ruling in California State Court Opioid Trial
November 22, 2021

Summary Toggle Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data Presented at the American Society for Dermatologic Surgery's Annual Meeting
November 18, 2021

Summary Toggle Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection
November 17, 2021

Summary Toggle Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Production of Critical Medicines
November 8, 2021

Summary Toggle Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP) Vials, Essential for COVID-19 Care
November 4, 2021

Summary Toggle Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance
November 2, 2021

Summary Toggle California State Court Issues Tentative Ruling in Endo's Favor Following Opioid Trial
October 25, 2021

Summary Toggle Endo Announces First-Ever XIAFLEX® (collagenase clostridium histolyticum) Television Commercial, Bent Carrot, and Branded Campaign to Raise Awareness of Peyronie's Disease
October 22, 2021

Summary Toggle Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data Analysis at Sexual Medicine Society of North America (SMSNA) Annual Meeting
October 5, 2021

Summary Toggle Endo to Announce Third Quarter 2021 Financial Results
September 30, 2021

Summary Toggle Endo Presents New Investigational Collagenase Clostridium Histolyticum (CCH) Survey Data at American Society for Surgery of the Hand (ASSH) Annual Meeting
September 28, 2021

Summary Toggle Endo Reaches Agreement in Principle to Settle Louisiana Governmental Opioid Cases and Claims
September 22, 2021

Summary Toggle Endo Launches First and Only Generic Version of Chantix® (varenicline) Tablets in the United States
September 9, 2021

Summary Toggle Endo Settles New York State Opioid Cases and Provides Update on Remaining Opioid Litigation
August 31, 2021

Summary Toggle Endo Comments on Non-Infringement Ruling in VASOSTRICT® Patent Litigation
August 5, 2021

Summary Toggle Endo Reports Second-Quarter 2021 Financial Results And Updates 2021 Financial Guidance
August 4, 2021

Summary Toggle Endo Announces Execution of Definitive Settlement Agreement and Release Resolving Tennessee State Court Case
July 29, 2021

Summary Toggle Endo Presents New Investigational Collagenase Clostridium Histolyticum Data at the American Podiatric Medical Association Annual Scientific Meeting
July 22, 2021

Summary Toggle Endo Announces Agreement in Principle to Settle Tennessee State Court Case
July 15, 2021

Summary Toggle Endo Comments on Tennessee Appeals Court Orders
June 24, 2021

Summary Toggle Endo to Announce Second Quarter 2021 Financial Results
June 24, 2021

Summary Toggle Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021
June 11, 2021

Summary Toggle Tennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment Against Endo
June 9, 2021

Summary Toggle Paladin Labs Inc. Announces Approval of Wakix® (pitolisant) in Canada
May 12, 2021

Summary Toggle Endo to Participate at 2021 RBC Capital Markets Global Healthcare Virtual Conference
May 6, 2021

Summary Toggle Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance
April 29, 2021

Summary Toggle Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021
April 27, 2021

Summary Toggle Endo Implements Board Succession Plan
April 13, 2021

Summary Toggle Endo to Announce First Quarter 2021 Financial Results
April 13, 2021

Summary Toggle Endo Announces Publication of Phase 3 Qwo® (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery
April 12, 2021

Summary Toggle ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba® (dalbavancin hydrochloride) in Canada
April 7, 2021

Summary Toggle Endo Comments on Entry of Default Liability Judgment in Tennessee State Court Case
March 11, 2021

Summary Toggle Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes
March 11, 2021

Summary Toggle Endo International plc Announces Proposed Private Offering Of Senior Secured Notes
March 4, 2021

Summary Toggle Endo International plc Commences Refinancing of its Existing Term Loan
February 25, 2021

Summary Toggle Endo Reports Fourth-Quarter And Full-Year 2020 Financial Results And Introduces 2021 Financial Guidance
February 17, 2021

Summary Toggle Endo to Participate at J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference
February 17, 2021

Summary Toggle Endo Appoints Jennifer M. Chao to Board of Directors
January 26, 2021

Summary Toggle Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results
January 5, 2021

Summary Toggle Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada
January 5, 2021

Summary Toggle Endo Aesthetics Launches "Really Cellulite" Campaign
January 4, 2021

Summary Toggle Endo Launches Authorized Generic Version of Amitiza® (lubiprostone) Capsules in the United States
December 18, 2020

Summary Toggle Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference
December 2, 2020

Summary Toggle Endo Completes Acquisition of BioSpecifics
November 18, 2020

Summary Toggle Endo to Participate In Upcoming Investor Conferences
November 18, 2020

Summary Toggle Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer
November 5, 2020

Summary Toggle Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance
November 5, 2020

Summary Toggle Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
November 2, 2020

Summary Toggle Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.
October 22, 2020

Summary Toggle Envarsus® PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan
October 19, 2020

Summary Toggle Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
October 9, 2020

Summary Toggle Endo Aesthetics Data to be Featured in Five Presentations at the American Society for Dermatologic Surgery's Annual Meeting (ASDS)
October 7, 2020

Summary Toggle Endo to Announce Third Quarter 2020 Financial Results
October 6, 2020

Summary Toggle Endo Releases First Environmental, Social and Governance Report
October 1, 2020

Summary Toggle Endo Begins Shipment of Generic Kuvan® Tablets and Powder for Oral Solution (sapropterin dihydrochloride)
September 25, 2020

Summary Toggle Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate
September 24, 2020

Summary Toggle Endo to Present Qwo™ (collagenase clostridium histolyticum-aaes) Data at Vegas Cosmetic Surgery & Aesthetic Dermatology (VCS)
September 8, 2020

Summary Toggle Endo to Participate at Citi 15th Annual BioPharma Virtual Conference
August 21, 2020

Summary Toggle Endo International plc Announces The Expiration And Final Tender Results Of Its Previously Announced Tender Offer
August 17, 2020

Summary Toggle Endo International plc Commences Tender Offer For Any And All Of Its Outstanding 5.75% Senior Notes Due 2022
August 5, 2020

Summary Toggle Endo Reports Second-Quarter 2020 Financial Results
July 30, 2020

Summary Toggle Endo Announces Second Quarter 2020 Earnings Call Time Change
July 29, 2020

Summary Toggle Endo Appoints M. Christine Smith, Ph.D. to Board of Directors
July 6, 2020

Summary Toggle U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite
June 17, 2020

Summary Toggle New Harris Poll Survey Shows 60% of Women Surveyed Feel It's Their Fault They Have Cellulite
June 16, 2020

Summary Toggle Endo to Announce Second-Quarter 2020 Financial Results
June 15, 2020

Summary Toggle Endo International plc Announces Final Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations
May 29, 2020

Summary Toggle Endo International plc Announces Early Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations
May 14, 2020

Summary Toggle Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
May 14, 2020

Summary Toggle Endo International plc Announces Proposed Exchange Offers And Consent Solicitations
May 7, 2020

Summary Toggle Endo Reports First-Quarter 2020 Financial Results and Provides Update Relating to COVID-19 Pandemic